Journals / Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi / 2011 / Cilt: 24 - Sayı: 4

If Kraepelin was still alive would dichotomy still survive?

Kraepelin bugün yaşasaydı dikotomi varlığını sürdürüyor olur muydu?

Pages
321–330
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Who knows if Kraepelin was still alive, maybe he would change his dichotomous view after a while.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Emil Kraepelin’s dichotomy, which has been providing a basis for psychiatric classification, has been valid for many years.
📊
Key Findings & Data:However, dimensional approaches based on the recent evidences from genetic, biological and clinical researches are in agreement, putting forth the need of this dichotomous view’s revision for consideration.
💡
Conclusion & Impact:Who knows if Kraepelin was still alive, maybe he would change his dichotomous view after a while.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Emil Kraepelin’s dichotomy, which has been providing a basis for psychiatric classification, has been valid for many years. However, dimensional approaches based on the recent evidences from genetic, biological and clinical researches are in agreement, putting forth the need of this dichotomous view’s revision for consideration. In particular, failure of describing many of the psychiatric cases in nature with descriptive paradigm used for psychiatric classification in clinical practice hinders clinicians’ effort for developing a common language and leads to the questioning of psychiatric diagnoses’ stability. In fact, it has been stated that the descriptive validity was low in the patient group with both psychotic and affective symptoms. It has also been informed that bipolar disorder and schizophrenia were presented with common symptom clusters in the studies evaluating the patterns of clinical symptom clustering with factor analysis. Moreover, some of the candidate genes developing susceptibility for each disorder have been shown to be common in the recent genetic studies, suggesting there is an overlap between these disorders. It appears that dimensional approach suggested by geneticists is consistent with the data from clinical researches. In the light of these clinical and genetic evidences, famous German scientist Emil Kraepelin’s ground-breaking dichotomous approach in psychiatry should be revised after a century. Who knows if Kraepelin was still alive, maybe he would change his dichotomous view after a while.

Özet

Emil Kraepelin’in psikiyatrik sınıflandırma sistemlerinin temelini oluşturan dikotomisi, uzun yıllardır geçerliliğini sürdürmektedir. Öte yandan, genetik, biyolojik ve klinik araştırmalardan elde edilen güncel kanıtlara dayanarak önerilen boyutsal modellemelerin benzerlik göstermesi bu dikotomik görüşün gözden geçirilme gerekliliğini ortaya koymaktadır. Özellikle klinik pratikte, psikiyatrik tanı sistemlerinde kullanılan tanımlayıcı (descriptive) paradigma ile doğada görülen azımsanmayacak sayıdaki psikiyatrik olgunun yeterince iyi tanımlanamaması, klinisyenlerin ortak dil geliştirme gayretlerini engellemekte ve psikiyatrik tanıların stabilitesinin sorgulanmasına neden olmaktadır. Nitekim, psikotik ve duygudurum belirtilerinin bir arada görüldüğü hasta grubunda tanısal geçerliliğin oldukça düşük olduğu bildirilmektedir. Bununla birlikte, klinik belirtilerin kümelenme şekillerini faktör analizi ile değerlendiren çalışmalarda, bipolar bozukluk ve şizofreninin belirli oranlarda ortak belirti kümelerini gösterdiği bildirilmektedir. Ayrıca güncel genetik araştırmalarda her iki hastalığa özgü yatkınlık oluşturan aday genler olduğu gösterilmekle birlikte, bazı ortak aday genlerin paylaşıldığı ve bir çakışmanın (overlap) olduğu öne sürülmektedir. Genetikçilerin önerdiği boyutsal yaklaşım, klinik araştırmalardan elde edilen bilgilerle uyumlu gözükmektedir. Tüm bu klinik ve genetik kanıtlar ışığında, ünlü Alman bilim adamı Emil Kraepelin’in psikiyatride çığır açan dikotomik yaklaşımının bir asır sonra gözden geçirilmesi gerekmektedir. Kim bilir Kraepelin günümüzde yaşasaydı, belki de kendi modelini bir süre sonra değiştirecekti.

🔖

Cite This Article

ALTINBAŞ, K., TUNÇ, S., YAZAR, M. S., ÖZÇETİNKAYA, S., GÜLÖKSÜZ, S., ORAL, E. T. (2011). If Kraepelin was still alive would dichotomy still survive?. Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi, Cilt: 24 - Sayı: 4, 321–330. https://ajindex.com/articles/218567

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Möller HJ. Systematic of psychiatric disorders between categorical and dimensional approaches; Kraepelin’s beyond. Eur Arch Psychiatry Clin Neurosci 2008; 258 (Suppl.2):48-73
  2. Craddock N, Owen MJ. The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry 2005; 186:364-366
  3. Kendler KS, Zerbin-Rudin E. Abstract and review of “zur erbpathologie der schizophrenie” (Contribution to the genetics of schizophrenia) 1916. Am J Med Genet 1996; 67:343-346
  4. Sorias S. Çoğul kişilik bozukluğu tanısının geçerliliği. Turk Psikiyatri Derg 2000; 11:251-268
  5. López J, Baca E, Botillo C, Quintero J, Navarro R, Negueruela M, Pérez M, Basurte I, Fernández A, Jiménez M, González J. Diagnostic errors and temporal stability in bipolar disorder. Actas Esp Psiquiatr 2008; 36:205-209
  6. Hafner H, an der Heiden W, Maurer K. Evidence for separate diseases? Stages of one disease or different combinations of symptom dimensions? Eur Arch Psychiatry Clin Neurosci 2008; 258 (Suppl.2):85-89
  7. Boks MP, Leask S, Vermunt JK, Kahn RS. The structure of psychosis revisited: The role of mood symptoms. Schizophr Res 2007; 93:178-185
  8. Altınbaş K, Guloksüz S, Cantürk YG, Yıldırım HE, Kalelioğlu T, Saatçioğlu Ö, Oral T. Hypomanic symptoms in schizophrenia and other psychotic disorders. presented in 4th Biennial Conference of the International Society for Bipolar Disorders, 2010
  9. Naber D, Holzbach R, Perro C, Hippius H. Clinical management of clozapine patients in relation to efficacy and side-effects. Br J Psychiatry Suppl 1992; 17:54-59
  10. Calabrese JR, Kimmel SE, Woyshville MJ, Rapport DJ, Faust CJ, Thompson PA, Meltzer HY. Clozapine for treatment-refractory mania. Am J Psychiatry 1996; 153:759-764
  11. Green AI, Tohen M, Patel JK, Banov M, DuRand C, Berman I, Chang H, Zarate C Jr, Posener J, Lee H, Dawson R, Richards C, Cole JO, Schatzberg AF. Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry 2000; 157:982-986
  12. Johnstone EC, Crow TJ, Frith CD, Owens DG. The Northwick Park “functional” psychosis study: diagnosis and treatment response. Lancet 1988; 2:119-125
  13. Glick ID, Bosch J, Casey DE. A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive. J Clin Psychopharmacol 2009; 29:267-271
  14. Demjaha A, Morgan K, Morgan C, Landau S, Dean K, Reichenberg A, Sham P, Fearon P, Hutchinson G, Jones PB, Murray RM, Dazzan P. Com